Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Share-based Compensation (2016 - 2026)

Aytu Biopharma has reported Share-based Compensation over the past 12 years, most recently at $283000.0 for Q4 2025.

  • Quarterly Share-based Compensation rose 87.42% to $283000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $649000.0 through Dec 2025, down 56.36% year-over-year, with the annual reading at $576000.0 for FY2025, 80.23% down from the prior year.
  • Share-based Compensation was $283000.0 for Q4 2025 at Aytu Biopharma, up from $114000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $3.1 million in Q4 2022 and troughed at $113000.0 in Q2 2025.
  • The 5-year median for Share-based Compensation is $900000.0 (2023), against an average of $856263.2.
  • Year-over-year, Share-based Compensation surged 233.85% in 2021 and then plummeted 82.86% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $1.2 million in 2021, then skyrocketed by 149.55% to $3.1 million in 2022, then tumbled by 73.26% to $820000.0 in 2023, then tumbled by 81.59% to $151000.0 in 2024, then soared by 87.42% to $283000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Share-based Compensation are $283000.0 (Q4 2025), $114000.0 (Q3 2025), and $113000.0 (Q2 2025).